Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steijaert

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Cell Chemical Biology|March 6, 2018
Repurposing High-Throughput Image Assays Enables Biological Activity Prediction for Drug DiscoveryJaak Simm, Günter Klambauer, Adam Arany, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2003
Partially T-cell-depleted allogeneic stem-cell transplantation for first-line treatment of multiple myeloma: a prospective evaluation of patients treated in the phase III study HOVON 24 MMHenk M Lokhorst, Christine M Segeren, Leo F Verdonck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2005
Impact of three courses of intensified CHOP prior to high-dose sequential therapy followed by autologous stem-cell transplantation as first-line treatment in poor-risk, aggressive non-hodgkin's lymphoma: comparative analysis of Dutch-Belgian Hemato-Oncology Cooperative Group Studies 27 and 40Gustaaf W van Imhoff, Bronno van der Holt, Marius A Mackenzie, et al.
Experimental Hematology|October 11, 2003
A randomized multicenter comparison of CD34(+)-selected progenitor cells from blood vs from bone marrow in recipients of HLA-identical allogeneic transplants for hematological malignanciesJan J Cornelissen, Bronno van der Holt, Eefke J Petersen, et al.
Nature Communications|May 1, 2021
Selective cell death in HIV-1-infected cells by DDX3 inhibitors leads to depletion of the inducible reservoirShringar Rao, Cynthia Lungu, Raquel Crespo, et al.
Leukemia Research|August 4, 2004
Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: a randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working Group for adultsSimon Daenen, Bronno van der Holt, Gregor E G Verhoef, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2003
CHOP compared with CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphomaJ K Doorduijn, B van der Holt, G W van Imhoff, et al.
Blood|November 29, 2002
Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 studyChristine M Segeren, Pieter Sonneveld, Bronno van der Holt, et al.
Cell Host & Microbe|November 18, 2022
Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protectionPhilip J M Brouwer, Aleksandar Antanasijevic, Adam J Ronk, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Cell Chemical Biology|March 6, 2018
Repurposing High-Throughput Image Assays Enables Biological Activity Prediction for Drug DiscoveryJaak Simm, Günter Klambauer, Adam Arany, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2003
Partially T-cell-depleted allogeneic stem-cell transplantation for first-line treatment of multiple myeloma: a prospective evaluation of patients treated in the phase III study HOVON 24 MMHenk M Lokhorst, Christine M Segeren, Leo F Verdonck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2005
Impact of three courses of intensified CHOP prior to high-dose sequential therapy followed by autologous stem-cell transplantation as first-line treatment in poor-risk, aggressive non-hodgkin's lymphoma: comparative analysis of Dutch-Belgian Hemato-Oncology Cooperative Group Studies 27 and 40Gustaaf W van Imhoff, Bronno van der Holt, Marius A Mackenzie, et al.
Experimental Hematology|October 11, 2003
A randomized multicenter comparison of CD34(+)-selected progenitor cells from blood vs from bone marrow in recipients of HLA-identical allogeneic transplants for hematological malignanciesJan J Cornelissen, Bronno van der Holt, Eefke J Petersen, et al.
Nature Communications|May 1, 2021
Selective cell death in HIV-1-infected cells by DDX3 inhibitors leads to depletion of the inducible reservoirShringar Rao, Cynthia Lungu, Raquel Crespo, et al.
Leukemia Research|August 4, 2004
Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: a randomised phase II trial from HOVON, the Dutch-Belgian Haemato-Oncology Working Group for adultsSimon Daenen, Bronno van der Holt, Gregor E G Verhoef, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 14, 2003
CHOP compared with CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphomaJ K Doorduijn, B van der Holt, G W van Imhoff, et al.
Blood|November 29, 2002
Overall and event-free survival are not improved by the use of myeloablative therapy following intensified chemotherapy in previously untreated patients with multiple myeloma: a prospective randomized phase 3 studyChristine M Segeren, Pieter Sonneveld, Bronno van der Holt, et al.
Cell Host & Microbe|November 18, 2022
Lassa virus glycoprotein nanoparticles elicit neutralizing antibody responses and protectionPhilip J M Brouwer, Aleksandar Antanasijevic, Adam J Ronk, et al.
Pageof 3